Quick Answer
MEDIFAST INC reported Total Revenue of $385.79 million for the year ending 2025.
- MEDIFAST INC showed a decrease of -36.0% in Total Revenue from 2024 to 2025.
- This data is from MEDIFAST INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $90.97 million | Q1 2013: $96.04 million | Q2 2013: $97.07 million | Q3 2013: $86.48 million | Q1 2014: $79.23 million | Q2 2014: $74.73 million | Q3 2014: $69.02 million | Q1 2015: $73.36 million | Q2 2015: $72.16 million | Q3 2015: $65.94 million | Q4 2015: $61.31 million | Q1 2016: $72.35 million | Q2 2016: $71.14 million | Q3 2016: $68.58 million | Q4 2016: $62.47 million | Q1 2017: $70.62 million | Q2 2017: $75.73 million | Q3 2017: $77.21 million | Q4 2017: $78.01 million | Q1 2018: $98.60 million | Q2 2018: $117.32 million | Q3 2018: $139.24 million | Q4 2018: $145.84 million | Q1 2019: $165.88 million | Q2 2019: $187.10 million | Q3 2019: $190.06 million | Q4 2019: $170.63 million | Q1 2020: $178.46 million | Q2 2020: $220.00 million | Q3 2020: $271.47 million | Q4 2020: $264.91 million | Q1 2021: $340.67 million | Q2 2021: $394.19 million | Q3 2021: $413.40 million | Q1 2022: $417.60 million | Q1 2022: $417.60 million | Q2 2022: $453.33 million | Q2 2022: $453.33 million | Q3 2022: $390.40 million | Q3 2022: $390.40 million | Q1 2023: $348.98 million | Q2 2023: $296.19 million | Q3 2023: $235.87 million | Q1 2024: $174.74 million | Q2 2024: $168.56 million | Q3 2024: $140.16 million | Q1 2025: $115.73 million | Q2 2025: $105.56 million | Q3 2025: $89.41 million.
- Over the full 17 years of available data (2009 to 2025), MEDIFAST INC's Total Revenue has grown by 127.3%.
- Historical annual values: Fiscal year 2025: $385.79 million | Fiscal year 2024: $602.46 million | Fiscal year 2023: $1.07 billion | Fiscal year 2022: $1.60 billion | Fiscal year 2021: $1.53 billion | Fiscal year 2020: $934.84 million | Fiscal year 2019: $713.67 million | Fiscal year 2018: $501.00 million | Fiscal year 2017: $301.56 million | Fiscal year 2016: $274.53 million | Fiscal year 2015: $272.77 million | Fiscal year 2014: $285.29 million | Fiscal year 2013: $324.05 million | Fiscal year 2012: $318.57 million | Fiscal year 2011: $298.19 million | Fiscal year 2010: $257.55 million | Fiscal year 2009: $169.74 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: